Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison-Reference-Cited by-同舟云学术

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison

Published:2016-01-14 Issue: Volume:6 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Loussouarn Gildas,Sternberg Damien,Nicole Sophie,Marionneau Céline,Le Bouffant Francoise,Toumaniantz Gilles,Barc Julien,Malak Olfat A.,Fressart Véronique,Péréon Yann,Baró Isabelle,Charpentier Flavien

Funder

Seventh Framework Programme

Association Française contre les Myopathies

Centre National de la Recherche Scientifique

Institut National de la Santé et de la Recherche Médicale

Université Pierre et Marie Curie

Agence Nationale de la Recherche

Fondation pour la Recherche Médicale

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference216 articles.

1. Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology;Abriel;J. Mol. Cell. Cardiol.,2010

2. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA);Ackerman;Heart Rhythm,2011

3. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome;Ackerman;JAMA,2001

4. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents;Aiba;Circ. Cardiovasc. Genet,2014

5. 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5;Allouis;Circ. Res,2006

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional effects of drugs and toxins interacting with NaV1.4;Frontiers in Pharmacology;2024-04-25

2. Skeletal muscle differentiation induces wide-ranging nucleosome repositioning in muscle gene promoters;Scientific Reports;2024-04-24

3. Change of voltage‐gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model;European Journal of Neuroscience;2024-04-22

4. Novel compound heterozygous mutations in SCN4A as a potential genetic cause contributing to myopathic manifestations: A case report and literature review;Heliyon;2024-04

5. Biophysical mechanisms of myocardium sodium channelopathies;Pflügers Archiv - European Journal of Physiology;2024-03-01